The lack of correlation between oseltamivir carboxylate
pharmacokinetics and influenza virus load likely reflected all
subjects receiving the same therapeutic intervention. The relatively
narrow range of oseltamivir carboxylate exposures produced
similar drug exposures, which precluded the
establishment of concentration-response relationships